In 2025 Truly Labs and Lumito AB will be collaborating to strengthen the offer within tissue analysis.
”We are really looking forward to working with Lumito to understand how their unique platform for tissue analysis can add value to our services within drug development. Specifically we are looking forward to adding better selectivity and sensitivity in combination with the possibility of quantifying expression levels of proteins in a better way”, says Karin von Wachenfeldt, CEO, and Charlott Brunmark, CSO, at Truly Labs.
Leave a reply